Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate
primary studies published RCT
Details- 2013
- Bianchi ML
Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection.
primary studies published RCT
Details- 2013
- Clancy JP
Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial
primary studies published RCT
Details- 2013
- Davies J
Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation.
primary studies published RCT
Details- 2013
- Davies JC
Randomised Clinical Trial: Lactobacillus Reuteri ATCC55730 in Cystic Fibrosis.
primary studies published RCT
Details- 2013
- Di Nardo G
Dietary essential amino acids are highly anabolic in pediatric patients with cystic fibrosis.
primary studies published RCT
Details- 2013
- Engelen MP
The effect of probiotics on fecal calprotectin in patients with cystic fibrosis.
primary studies published RCT
Details- 2013
- Fallahi G
Tobramycin inhalation powder manufactured by improved process in cystic fibrosis: the randomized EDIT trial.
primary studies published RCT
Details- 2013
- Galeva I
Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.
primary studies published RCT
Details- 2013
- Gifford AH
A randomized controlled trial of inhaled l-Arginine in patients with cystic fibrosis.
primary studies published RCT
Details- 2013
- Grasemann H